文献速递中医骨伤中药与中成药合理使用针灸推拿

「肾主骨」理论的现代再解读:脑-骨轴与神经-内分泌-免疫网络及中药干预策略

A modern reinterpretation of the "kidney governs bone" theory: systemic regulation of the neuro-endocrine-immune network via the brain-bone axis and traditional chinese medicine intervention strategies.
PubMed 文献 · Front Pharmacol · 2026-07-29

本文基于现代医学研究,提出「肾主骨」理论的疗效可通过神经-内分泌-免疫网络的系统性调节部分解释,并构建了「脑-骨轴」框架及「中央-外周-局部」三级调控模型。文章系统评估了补肾中药、活血法及针灸等干预在该网络中的分层多靶点作用,并指出时空异质性、网络复杂性和临床转化缺口等挑战。

要点

  • 「肾主骨」可从「脑-骨轴」视角理解为神经-内分泌-免疫网络的系统性调控。
  • 补肾中药调节下丘脑-垂体轴维持内分泌稳态。
  • 针灸通过胆碱能抗炎通路、M2巨噬细胞极化等重塑骨免疫微环境。

核心结论

  • 「肾主骨」的现代科学内涵体现在神经-内分泌-免疫网络的系统性调节中,该跨学科方向为中医骨伤从经验医学向系统医学转化提供理论突破。

研究设计与样本

  • 本文为基于现有证据的理论综述与假说提出,未报告系统检索范围、样本量或原始研究数据。

主要发现

  • 补肾中药调节下丘脑-垂体轴以维持内分泌稳态。
  • 补肾活血法及针灸等外治法通过调节交感张力、上调CGRP等神经肽实现「神经-血管-成骨」协同。
  • 针灸通过激活胆碱能抗炎通路、促进M2巨噬细胞极化、抑制NLRP3炎症小体激活来重塑骨免疫微环境。

关键数值与推荐

  • 提出三个概念框架:将「肾主骨」从「肾-骨」内分泌轴扩展为以「脑-骨轴」为中心的系统调控框架。
  • 构建「中央-外周-局部」三级调控模型以整合神经-内分泌-免疫网络的分层交互。
  • 提出中药「分层干预」策略,明确不同治则在三个网络层面的靶点差异。

临床怎么用

  • 临床可依据「脑-骨轴」框架理解补肾中药与针灸在神经-内分泌-免疫网络中的分层多靶点作用。
  • 补肾中药侧重于下丘脑-垂体轴调控,针灸等外治法则侧重于神经-血管-成骨协同与骨免疫微环境重塑。

局限性

  • 当前挑战包括时空异质性、网络复杂性和临床转化缺口。
  • 所提假说需在多样病理情境中进一步验证。
  • 未来研究需采用光遗传学、多组学整合和器官芯片等技术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The traditional Chinese medicine (TCM) theory of "Kidney Governs Bone' has been progressively validated in modern medical research. However, a purely endocrinological perspective cannot fully explain its regulatory implications under complex conditions such as stress, inflammation, and nerve injury. As bone metabolism research shifts toward a systemic regulatory paradigm, the "brain-bone axis' provides a new framework for reinterpreting "Kidney Governs Bone.' Based on current evidence, the core scientific proposition of this article is that we propose the hypothesis that the therapeutic effects of TCM's "Kidney Governs Bone' theory can be partially explained by systemic regulation of the neuro-endocrine-immune network, and that the therapeutic efficacy of TCM interventions may be related to their ability for layered, multi-target regulation within this network. This proposition requires further validation in diverse pathological contexts. Based on this proposition, we propose three conceptual frameworks: ① extending "Kidney Governs Bone' from the traditional "kidney-bone' endocrine axis to a systemic regulatory framework centered on the "brain-bone axis'; ② constructing a three-level "central-peripheral-local' regulatory model that systematically integrates the hierarchical interactions within the neuro-endocrine-immune network; and ③ proposing a "stratified intervention' strategy for TCM, clarifying the target differences among different therapeutic principles across the three network levels. Using this framework, we systematically evaluate the mechanisms of TCM interventions: kidney-tonifying herbs regulate the hypothalamic-pituitary axis to maintain endocrine homeostasis; kidney-tonifying and blood-activating methods, as well as acupuncture and other external therapies, achieve "neuro-vascular-osteogenic' synergy by modulating sympathetic tone and upregulating neuropeptides such as CGRP; acupuncture and moxibustion remodel the bone immune microenvironment by activating the cholinergic anti-inflammatory pathway, promoting M2 macrophage polarization, and inhibiting NLRP3 inflammasome activation. Current challenges include spatiotemporal heterogeneity, network complexity, and clinical translation gaps. Future studies should employ technologies such as optogenetics, multi-omics integration, and organoid-on-a-chip platforms. The modern scientific connotation of "Kidney Governs Bone' is deeply reflected in the systemic regulation of the neuro-endocrine-immune network, and this interdisciplinary direction provides a crucial theoretical breakthrough for transforming TCM orthopedics from empirical medicine toward systems medicine.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Dong J, Peng Z, Chen T, et al. A modern reinterpretation of the "kidney governs bone" theory: systemic regulation of the neuro-endocrine-immune network via the brain-bone axis and traditional chinese medicine intervention strategies. Front Pharmacol. 2026. PMID: 42591384. doi:10.3389/fphar.2026.1862657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。